Research Article
Does i-T744C P2Y12 Polymorphism Modulate Clopidogrel Response among Moroccan Acute Coronary Syndromes Patients?
Table 5
i-T744C P2Y12 rs2046934 genotypes distribution versus risk factors.
| Risk factor | SCA patients | value (<0.05) | Wild-type% | Heterozygous% | Mutant% |
| Familial ACD | | | | | Presence | 0 | 100 | 0 | | Absence | 71.4 | 17.2 | 11.4 | | Personal ACD | | | | 0.6 | Presence | 75 | 17.9 | 7.1 | | Absence | 65.9 | 20.5 | 13.6 | | HTA | | | | 0.8 | Presence | 71.4 | 17.2 | 11.4 | | Absence | 67.6 | 21.6 | 10.8 | | Smoking | | | | 0.51 | Presence | 70 | 23.3 | 6.7 | | Absence | 69 | 16.7 | 14.3 | | Diabetes | | | | 0.71 | Presence | 65.5 | 24.2 | 10.3 | | Absence | 72.1 | 16.3 | 11.6 | | Dyslipidemia | | | | 0.8 | Presence | 71.4 | 21.4 | 7.2 | | Absence | 69 | 19 | 12 | |
|
|
Statistically significant.
|